Literature DB >> 20484115

Gyrate: CCM3 dances with a different angiogenic partner.

Laura A Dyer1, Andrea L Portbury, Cam Patterson.   

Abstract

A healthy vasculature is an essential component of development and is regulated by different signaling pathways. One of the most critical pathways involved is the vascular endothelial growth factor (VEGF) pathway. Components of this pathway serve as the first marker of primitive endothelial cells and are instrumental in inducing the initial differentiation of endothelial cells and later refining them into either arteries or veins. However, the regulation of VEGF signaling remains a mystery, with most studies focusing on the downstream components of this signaling cascade. New evidence shows that the protein cerebral cavernous malformation 3 (CCM3) is a key regulator of the VEGF pathway, bringing to light a previously unknown component of the VEGF signaling axis and opening the door to an exciting new era of vasculogenic research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484115      PMCID: PMC3328216          DOI: 10.1126/scisignal.3122pe17

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  19 in total

1.  From mesoderm to blood islands: patterns of key molecules during yolk sac erythropoiesis.

Authors:  K Minko; K Bollerot; C Drevon; M-F Hallais; T Jaffredo
Journal:  Gene Expr Patterns       Date:  2003-06       Impact factor: 1.224

2.  Functional arterial and venous fate is determined by graded VEGF signaling and notch status during embryonic stem cell differentiation.

Authors:  Fredrik Lanner; Marcus Sohl; Filip Farnebo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12-21       Impact factor: 8.311

Review 3.  The regulation of blood vessel growth by vascular endothelial growth factor.

Authors:  N Ferrara; H Heinsohn; C E Walder; S Bunting; G R Thomas
Journal:  Ann N Y Acad Sci       Date:  1995-03-27       Impact factor: 5.691

4.  Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity.

Authors:  Li-Ru You; Fu-Jung Lin; Christopher T Lee; Francesco J DeMayo; Ming-Jer Tsai; Sophia Y Tsai
Journal:  Nature       Date:  2005-05-05       Impact factor: 49.962

5.  A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein.

Authors:  Marilyn Goudreault; Lisa M D'Ambrosio; Michelle J Kean; Michael J Mullin; Brett G Larsen; Amy Sanchez; Sidharth Chaudhry; Ginny I Chen; Frank Sicheri; Alexey I Nesvizhskii; Ruedi Aebersold; Brian Raught; Anne-Claude Gingras
Journal:  Mol Cell Proteomics       Date:  2008-09-08       Impact factor: 5.911

6.  The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF.

Authors:  Stella Pearson; Patrycja Sroczynska; Georges Lacaud; Valerie Kouskoff
Journal:  Development       Date:  2008-03-13       Impact factor: 6.868

7.  PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway.

Authors:  Xi Ma; Hongshan Zhao; Jingxuan Shan; Feng Long; Yaoyao Chen; Yingyu Chen; Yingmei Zhang; Xiao Han; Dalong Ma
Journal:  Mol Biol Cell       Date:  2007-03-14       Impact factor: 4.138

8.  Apoptotic functions of PDCD10/CCM3, the gene mutated in cerebral cavernous malformation 3.

Authors:  Leiling Chen; Gamze Tanriover; Hiroko Yano; Robert Friedlander; Angeliki Louvi; Murat Gunel
Journal:  Stroke       Date:  2009-02-26       Impact factor: 7.914

9.  Hematopoietic induction and respecification of A-P identity by visceral endoderm signaling in the mouse embryo.

Authors:  M Belaoussoff; S M Farrington; M H Baron
Journal:  Development       Date:  1998-12       Impact factor: 6.868

10.  HOXA13 Is essential for placental vascular patterning and labyrinth endothelial specification.

Authors:  Carley A E Shaut; Douglas R Keene; Lise K Sorensen; Dean Y Li; H Scott Stadler
Journal:  PLoS Genet       Date:  2008-05-16       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.